UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Young adults’ desired life tradeoffs: love first, sex last

Scientific reports, 2024-08, Vol.14 (1), p.19680-11

2024

Volltextzugriff (PDF)

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

The lancet oncology, 2014-10, Vol.15 (11), p.1207-1214

2014

Volltextzugriff (PDF)

Social exclusion: more important to human females than males

PloS one, 2013-02, Vol.8 (2), p.e55851-e55851

2013

Volltextzugriff (PDF)

Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients

Gynecologic oncology, 2013-11, Vol.131 (2), p.352-356

2013

Volltextzugriff (PDF)

Care farming: Rehabilitation or punishment? A qualitative exploration of the use of care farming within community orders

Health & place, 2019-07, Vol.58, p.102156-102156, Article 102156

2019

Volltextzugriff (PDF)

A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer

European journal of cancer (1990), 2013-09, Vol.49 (14), p.2972-2978

2013

Volltextzugriff (PDF)

Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Clinical cancer research, 2022-10, Vol.28 (19), p.4186-4193

2022

Volltextzugriff (PDF)

Evaluating the prevalence and risk factors for macrolide resistance in Mycoplasma genitalium using a newly developed qPCR assay

PloS one, 2020-10, Vol.15 (10), p.e0240836-e0240836

2020

Volltextzugriff (PDF)

Clinical use of STOP-BANG and ESS questionnaires in the evaluation of obstructive sleep apnoea–related risk factors for motor vehicle accidents among public transport drivers in Delhi, India

Sleep & breathing, 2021-09, Vol.25 (3), p.1461-1466

2021

Volltextzugriff (PDF)

Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer

Gynecologic oncology, 2021-11, Vol.163 (2), p.254-261

2021

Volltextzugriff (PDF)

Improving the palliative-procedure decision-making process for patients with peritoneal carcinomatosis: A secondary analysis

Gynecologic oncology, 2024-09, Vol.188, p.125-130

2024

Volltextzugriff (PDF)

Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas

Gynecologic oncology, 2011-10, Vol.123 (1), p.5-12

2011

Volltextzugriff (PDF)

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

Journal of clinical oncology, 2024-07, Vol.42 (21), p.2537-2545

2024

Volltextzugriff (PDF)

Sensitive and specific assay for the simultaneous detection of Mycoplasma genitalium and macrolide resistance-associated mutations

European journal of clinical microbiology & infectious diseases, 2018-11, Vol.37 (11), p.2137-2144

2018

Volltextzugriff (PDF)

Pharmacy benefits and the use of drugs by the chronically ill

JAMA : the journal of the American Medical Association, 2004-05, Vol.291 (19), p.2344

2004

Volltextzugriff (PDF)

Male Urethral Stricture Disease

The Journal of urology, 2007-05, Vol.177 (5), p.1667-1674

2007

Volltextzugriff (PDF)

Cesarean delivery outcomes after a prolonged second stage of labor

American journal of obstetrics and gynecology, 2007-09, Vol.197 (3), p.306.e1-306.e5

2007

Volltextzugriff (PDF)

Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial

JCO precision oncology, 2024-05, Vol.8 (8), p.e2300693

2024

Volltextzugriff (PDF)

Kidney Cancer

The Journal of urology, 2007-06, Vol.177 (6), p.2006-2019

2007

Volltextzugriff (PDF)

Clinical-Epidemiological Features of 13 Cases of Melioidosis in Brazil

Journal of Clinical Microbiology, 2012-10, Vol.50 (10), p.3349-3352

2012

Volltextzugriff (PDF)

Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma

Cancer cell, 2014-01, Vol.25 (1), p.49-63

2014

Volltextzugriff (PDF)

C‐terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by c‐jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2013-01, Vol.57 (1), p.131-139

2013

Volltextzugriff (PDF)

Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy

The American journal of managed care, 2006-01, Vol.12 (1), p.21-28

2006

Volltextzugriff (PDF)

Maternal glucose response to betamethasone administration

American journal of perinatology, 2015-01, Vol.30 (2), p.143-148

2015

Volltextzugriff (PDF)

1 – 25 von 1.089

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.013)
Mit Volltextzugriff
(833)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(1.086)
Science & Technology
(934)
Female
(929)
Life Sciences & Biomedicine
(896)
Male
(795)
Middle Aged
(689)
Biological And Medical Sciences
(435)
Aged
(426)
Medical Sciences
(413)
Adolescent
(358)
Psychiatry
(175)
Young Adult
(151)
Psychology. Psychoanalysis. Psychiatry
(143)
Aged, 80 And Over
(140)
Child
(130)
Risk Factors
(130)
Psychopathology. Psychiatry
(118)
Treatment Outcome
(116)
Follow-Up Studies
(106)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Young adults’ desired life tradeoffs: love first, sex last

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

Social exclusion: more important to human females than males

Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients

Care farming: Rehabilitation or punishment? A qualitative exploration of the use of care farming within community orders

A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer

Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Evaluating the prevalence and risk factors for macrolide resistance in Mycoplasma genitalium using a newly developed qPCR assay

Clinical use of STOP-BANG and ESS questionnaires in the evaluation of obstructive sleep apnoea–related risk factors for motor vehicle accidents among public transport drivers in Delhi, India

Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer

Improving the palliative-procedure decision-making process for patients with peritoneal carcinomatosis: A secondary analysis

Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib

Sensitive and specific assay for the simultaneous detection of Mycoplasma genitalium and macrolide resistance-associated mutations

Pharmacy benefits and the use of drugs by the chronically ill

Male Urethral Stricture Disease

Cesarean delivery outcomes after a prolonged second stage of labor

Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial

Kidney Cancer

Clinical-Epidemiological Features of 13 Cases of Melioidosis in Brazil

Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma

C‐terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by c‐jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma

Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy

Maternal glucose response to betamethasone administration

Aktive Filter

Suchergebnisse filtern